

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.03004432 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.60356810 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 7.60356810 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.79438336 |
| 5 | respiratory electron transport chain (GO:0022904) | 6.41857094 |
| 6 | electron transport chain (GO:0022900) | 6.28183034 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 5.66186927 |
| 8 | oxidative phosphorylation (GO:0006119) | 5.13503597 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.12370987 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 5.12370987 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.12370987 |
| 12 | protein complex biogenesis (GO:0070271) | 5.06569970 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.94784631 |
| 14 | proteasome assembly (GO:0043248) | 4.92697615 |
| 15 | protein neddylation (GO:0045116) | 4.87627883 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.69824701 |
| 17 | cullin deneddylation (GO:0010388) | 4.35392173 |
| 18 | ATP biosynthetic process (GO:0006754) | 4.33712801 |
| 19 | hydrogen ion transmembrane transport (GO:1902600) | 4.24401744 |
| 20 | respiratory chain complex IV assembly (GO:0008535) | 4.18635028 |
| 21 | protein targeting to mitochondrion (GO:0006626) | 4.18506506 |
| 22 | establishment of protein localization to mitochondrion (GO:0072655) | 4.14057798 |
| 23 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.12801667 |
| 24 | protein deneddylation (GO:0000338) | 4.11983898 |
| 25 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.09543643 |
| 26 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.08688525 |
| 27 | inner mitochondrial membrane organization (GO:0007007) | 4.08455231 |
| 28 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.93485225 |
| 29 | dopamine transport (GO:0015872) | 3.91404811 |
| 30 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.89297960 |
| 31 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.89297960 |
| 32 | protein localization to mitochondrion (GO:0070585) | 3.88541261 |
| 33 | DNA deamination (GO:0045006) | 3.88168601 |
| 34 | platelet dense granule organization (GO:0060155) | 3.86916237 |
| 35 | cytochrome complex assembly (GO:0017004) | 3.85439665 |
| 36 | pseudouridine synthesis (GO:0001522) | 3.83669260 |
| 37 | rRNA modification (GO:0000154) | 3.80583674 |
| 38 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.75944051 |
| 39 | regulation of mitochondrial translation (GO:0070129) | 3.74263733 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.74258823 |
| 41 | proton transport (GO:0015992) | 3.72382597 |
| 42 | ribosomal small subunit assembly (GO:0000028) | 3.71034914 |
| 43 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.70400186 |
| 44 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.70400186 |
| 45 | regulation of cellular respiration (GO:0043457) | 3.66883487 |
| 46 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.66179231 |
| 47 | peptidyl-histidine modification (GO:0018202) | 3.65777958 |
| 48 | hydrogen transport (GO:0006818) | 3.64116779 |
| 49 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.60732897 |
| 50 | negative regulation of ligase activity (GO:0051352) | 3.60732897 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.57169653 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.55141165 |
| 53 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.55141165 |
| 54 | ribosomal small subunit biogenesis (GO:0042274) | 3.55068150 |
| 55 | termination of RNA polymerase III transcription (GO:0006386) | 3.53462918 |
| 56 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.53462918 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.51913335 |
| 58 | aerobic respiration (GO:0009060) | 3.49575234 |
| 59 | viral transcription (GO:0019083) | 3.49275654 |
| 60 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.48661354 |
| 61 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.48661354 |
| 62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.48661354 |
| 63 | GTP biosynthetic process (GO:0006183) | 3.39612701 |
| 64 | tricarboxylic acid cycle (GO:0006099) | 3.38849422 |
| 65 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.38268017 |
| 66 | sequestering of actin monomers (GO:0042989) | 3.37694591 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.35493566 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.35493566 |
| 69 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.35352605 |
| 70 | translational termination (GO:0006415) | 3.35305390 |
| 71 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.34400696 |
| 72 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.33858540 |
| 73 | positive regulation of mitochondrial fission (GO:0090141) | 3.32541070 |
| 74 | mannosylation (GO:0097502) | 3.31528629 |
| 75 | maturation of 5.8S rRNA (GO:0000460) | 3.30792714 |
| 76 | NADH metabolic process (GO:0006734) | 3.30648472 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.29309475 |
| 78 | protein-cofactor linkage (GO:0018065) | 3.28770238 |
| 79 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.28580674 |
| 80 | mitochondrial transport (GO:0006839) | 3.28502552 |
| 81 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.27169473 |
| 82 | regulation of cellular amine metabolic process (GO:0033238) | 3.25075136 |
| 83 | quinone biosynthetic process (GO:1901663) | 3.24708001 |
| 84 | ubiquinone biosynthetic process (GO:0006744) | 3.24708001 |
| 85 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.23826255 |
| 86 | rRNA methylation (GO:0031167) | 3.23825334 |
| 87 | base-excision repair, AP site formation (GO:0006285) | 3.23518646 |
| 88 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.22629196 |
| 89 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.22629196 |
| 90 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.21711333 |
| 91 | RNA capping (GO:0036260) | 3.20946348 |
| 92 | 7-methylguanosine RNA capping (GO:0009452) | 3.20946348 |
| 93 | 7-methylguanosine mRNA capping (GO:0006370) | 3.20655582 |
| 94 | regulation of oxidative phosphorylation (GO:0002082) | 3.20097301 |
| 95 | translational elongation (GO:0006414) | 3.18466512 |
| 96 | translation (GO:0006412) | 3.12687338 |
| 97 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.12051226 |
| 98 | kynurenine metabolic process (GO:0070189) | 3.09473590 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 3.03525004 |
| 100 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.01780387 |
| 101 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.01026951 |
| 102 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98776486 |
| 103 | L-methionine biosynthetic process (GO:0071265) | 2.97318272 |
| 104 | amino acid salvage (GO:0043102) | 2.97318272 |
| 105 | L-methionine salvage (GO:0071267) | 2.97318272 |
| 106 | maturation of SSU-rRNA (GO:0030490) | 2.97121396 |
| 107 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.96638624 |
| 108 | iron-sulfur cluster assembly (GO:0016226) | 2.96295096 |
| 109 | metallo-sulfur cluster assembly (GO:0031163) | 2.96295096 |
| 110 | protein targeting to ER (GO:0045047) | 2.96148450 |
| 111 | ubiquinone metabolic process (GO:0006743) | 2.92565250 |
| 112 | tRNA processing (GO:0008033) | 2.92490503 |
| 113 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92197965 |
| 114 | indole-containing compound catabolic process (GO:0042436) | 2.88864773 |
| 115 | indolalkylamine catabolic process (GO:0046218) | 2.88864773 |
| 116 | tryptophan catabolic process (GO:0006569) | 2.88864773 |
| 117 | signal peptide processing (GO:0006465) | 2.88264369 |
| 118 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.84956786 |
| 119 | positive regulation of ligase activity (GO:0051351) | 2.77287628 |
| 120 | negative regulation of mast cell activation (GO:0033004) | 2.68840547 |
| 121 | mitochondrial RNA metabolic process (GO:0000959) | 2.68161203 |
| 122 | deoxyribonucleotide catabolic process (GO:0009264) | 2.65925591 |
| 123 | purine nucleotide salvage (GO:0032261) | 2.56538763 |
| 124 | cellular ketone body metabolic process (GO:0046950) | 2.56410967 |
| 125 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.52990133 |
| 126 | tryptophan metabolic process (GO:0006568) | 2.52936715 |
| 127 | amine catabolic process (GO:0009310) | 2.51690476 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 2.51690476 |
| 129 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51492415 |
| 130 | methionine biosynthetic process (GO:0009086) | 2.51435378 |
| 131 | indolalkylamine metabolic process (GO:0006586) | 2.49813941 |
| 132 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.49597430 |
| 133 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.49075973 |
| 134 | positive regulation of prostaglandin secretion (GO:0032308) | 2.48669316 |
| 135 | C-terminal protein lipidation (GO:0006501) | 2.47378295 |
| 136 | deoxyribose phosphate catabolic process (GO:0046386) | 2.46967750 |
| 137 | tRNA metabolic process (GO:0006399) | 2.46305108 |
| 138 | organelle membrane fusion (GO:0090174) | 2.45347212 |
| 139 | positive regulation of cell cycle arrest (GO:0071158) | 2.44407506 |
| 140 | purine-containing compound salvage (GO:0043101) | 2.43332396 |
| 141 | tRNA modification (GO:0006400) | 2.42198010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.09770955 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.53715747 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.36017985 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.34183577 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.13279197 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.09629333 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.95047122 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.81681790 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.73311490 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.56010743 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.51311035 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.39784731 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.04298320 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.00937197 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.99737571 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.87235134 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.80154830 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.73298567 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.70797992 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.68532756 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.61859880 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61282895 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.51381197 |
| 24 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.47161187 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.41609347 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.38601302 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.38323479 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.32728861 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.29711122 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.25423973 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17214712 |
| 32 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.14907670 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.11977490 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11322424 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02101205 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97675265 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.93783370 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91117407 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.88878978 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82219058 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.74770235 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74226629 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67045124 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56335068 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.55565034 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51121108 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49480945 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48281017 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47591209 |
| 50 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.42458652 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41607796 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37717905 |
| 53 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34612115 |
| 54 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.34606278 |
| 55 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.33365782 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31868625 |
| 57 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31391931 |
| 58 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.29348554 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28348484 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28317846 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26249312 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26016514 |
| 63 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18028468 |
| 64 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17293071 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17271720 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15266985 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15083403 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14951941 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14048988 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11482517 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11480482 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11202489 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10960293 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10394528 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09446839 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09262232 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09126708 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07683856 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04575982 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01328824 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01260615 |
| 82 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00104315 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99414954 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99066416 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98929757 |
| 86 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.96915861 |
| 87 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95660719 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95587565 |
| 89 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.93531026 |
| 90 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91964467 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91485804 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91402032 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90418145 |
| 94 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90245021 |
| 95 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89000504 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88658439 |
| 97 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88616205 |
| 98 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85848872 |
| 99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85848872 |
| 100 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.85537264 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85020041 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 0.84947890 |
| 103 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84920457 |
| 104 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84715515 |
| 105 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84069936 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83813877 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83738770 |
| 108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82813592 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82763951 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82602033 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.82554560 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82431996 |
| 113 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.81963499 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80745294 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80682396 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80323760 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80015313 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79881315 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79315010 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79296330 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.78779980 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 0.77213442 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77030689 |
| 124 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.76733445 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75258621 |
| 126 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.74834358 |
| 127 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74294508 |
| 128 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.73420650 |
| 129 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.73299257 |
| 130 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.72354920 |
| 131 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.71285687 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70549375 |
| 133 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.69413270 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68289545 |
| 135 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.68090619 |
| 136 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.67495667 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.66614318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.15320366 |
| 2 | MP0001529_abnormal_vocalization | 3.51379134 |
| 3 | MP0001905_abnormal_dopamine_level | 3.07495604 |
| 4 | MP0006036_abnormal_mitochondrial_physio | 3.05040525 |
| 5 | MP0003646_muscle_fatigue | 3.03653190 |
| 6 | MP0002822_catalepsy | 2.99336597 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.97680567 |
| 8 | MP0002736_abnormal_nociception_after | 2.91643830 |
| 9 | MP0003195_calcinosis | 2.82454918 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.74570542 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.57456245 |
| 12 | MP0006035_abnormal_mitochondrial_morpho | 2.55864873 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.48682947 |
| 14 | MP0000749_muscle_degeneration | 2.43939272 |
| 15 | MP0000015_abnormal_ear_pigmentation | 2.35179897 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.34265722 |
| 17 | MP0004142_abnormal_muscle_tone | 2.27308380 |
| 18 | MP0005671_abnormal_response_to | 2.27154491 |
| 19 | MP0003186_abnormal_redox_activity | 2.26801915 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.21519816 |
| 21 | MP0009745_abnormal_behavioral_response | 2.17532925 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.12840263 |
| 23 | MP0009785_altered_susceptibility_to | 2.11655352 |
| 24 | MP0009046_muscle_twitch | 2.11225425 |
| 25 | MP0002064_seizures | 2.09115684 |
| 26 | MP0004859_abnormal_synaptic_plasticity | 2.02610242 |
| 27 | MP0002272_abnormal_nervous_system | 2.01174314 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.97458689 |
| 29 | MP0008058_abnormal_DNA_repair | 1.90700377 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.90494793 |
| 31 | MP0005410_abnormal_fertilization | 1.89590444 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.83581572 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.83063671 |
| 34 | MP0009764_decreased_sensitivity_to | 1.81339693 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.79901743 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.78423998 |
| 37 | MP0001984_abnormal_olfaction | 1.77648237 |
| 38 | MP0001970_abnormal_pain_threshold | 1.77443574 |
| 39 | MP0000751_myopathy | 1.77299143 |
| 40 | MP0004147_increased_porphyrin_level | 1.74471263 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.71351882 |
| 42 | MP0004084_abnormal_cardiac_muscle | 1.68991980 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.67466871 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.66930967 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.64717271 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.58567454 |
| 47 | MP0004270_analgesia | 1.57819825 |
| 48 | MP0008872_abnormal_physiological_respon | 1.54026494 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.46056817 |
| 50 | MP0009840_abnormal_foam_cell | 1.45995131 |
| 51 | MP0001790_abnormal_immune_system | 1.44438340 |
| 52 | MP0005387_immune_system_phenotype | 1.44438340 |
| 53 | MP0002254_reproductive_system_inflammat | 1.44329448 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.43886427 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.42309733 |
| 56 | MP0003724_increased_susceptibility_to | 1.41432829 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.40800555 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.39490435 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37091465 |
| 60 | MP0005330_cardiomyopathy | 1.36042602 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.35817939 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.34785852 |
| 63 | MP0006082_CNS_inflammation | 1.34483846 |
| 64 | MP0005451_abnormal_body_composition | 1.34482436 |
| 65 | MP0000685_abnormal_immune_system | 1.34472096 |
| 66 | MP0002723_abnormal_immune_serum | 1.32695860 |
| 67 | MP0004924_abnormal_behavior | 1.32424226 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.32424226 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.31653030 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.30636581 |
| 71 | MP0005332_abnormal_amino_acid | 1.30463597 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.29371453 |
| 73 | MP0001853_heart_inflammation | 1.29251647 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 1.26277908 |
| 75 | MP0005025_abnormal_response_to | 1.25013739 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.23819802 |
| 77 | MP0001800_abnormal_humoral_immune | 1.23787761 |
| 78 | MP0008260_abnormal_autophagy | 1.23029183 |
| 79 | MP0005266_abnormal_metabolism | 1.22067785 |
| 80 | MP0005409_darkened_coat_color | 1.21668435 |
| 81 | MP0002972_abnormal_cardiac_muscle | 1.21224946 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.20556656 |
| 83 | MP0008007_abnormal_cellular_replicative | 1.20072847 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.16841456 |
| 85 | MP0002102_abnormal_ear_morphology | 1.16166352 |
| 86 | MP0004484_altered_response_of | 1.15992379 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.15593944 |
| 88 | MP0008469_abnormal_protein_level | 1.15538491 |
| 89 | MP0000358_abnormal_cell_content/ | 1.15409921 |
| 90 | MP0002419_abnormal_innate_immunity | 1.14466035 |
| 91 | MP0005253_abnormal_eye_physiology | 1.14160165 |
| 92 | MP0005083_abnormal_biliary_tract | 1.12738796 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.12594489 |
| 94 | MP0002420_abnormal_adaptive_immunity | 1.11734107 |
| 95 | MP0001819_abnormal_immune_cell | 1.10811778 |
| 96 | MP0003122_maternal_imprinting | 1.10599825 |
| 97 | MP0008932_abnormal_embryonic_tissue | 1.09502692 |
| 98 | MP0004957_abnormal_blastocyst_morpholog | 1.09355007 |
| 99 | MP0005670_abnormal_white_adipose | 1.08076011 |
| 100 | MP0000371_diluted_coat_color | 1.07470960 |
| 101 | MP0010094_abnormal_chromosome_stability | 1.07313986 |
| 102 | MP0002184_abnormal_innervation | 1.07259392 |
| 103 | MP0000343_altered_response_to | 1.06510517 |
| 104 | MP0005423_abnormal_somatic_nervous | 1.05029641 |
| 105 | MP0000747_muscle_weakness | 1.04779881 |
| 106 | MP0002876_abnormal_thyroid_physiology | 1.04333531 |
| 107 | MP0009697_abnormal_copulation | 1.04210958 |
| 108 | MP0002095_abnormal_skin_pigmentation | 1.03193535 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 1.02568908 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01861390 |
| 111 | MP0005408_hypopigmentation | 1.00221329 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.99667935 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.98791342 |
| 114 | MP0001486_abnormal_startle_reflex | 0.97924024 |
| 115 | MP0003136_yellow_coat_color | 0.97655676 |
| 116 | MP0005365_abnormal_bile_salt | 0.94723506 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.94250725 |
| 118 | MP0000689_abnormal_spleen_morphology | 0.94006680 |
| 119 | MP0005310_abnormal_salivary_gland | 0.93867083 |
| 120 | MP0003436_decreased_susceptibility_to | 0.93783238 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.93213464 |
| 122 | MP0004043_abnormal_pH_regulation | 0.92971429 |
| 123 | MP0001545_abnormal_hematopoietic_system | 0.92834100 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.92834100 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.92793771 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92722223 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.91545548 |
| 128 | MP0001764_abnormal_homeostasis | 0.91349693 |
| 129 | MP0001188_hyperpigmentation | 0.91164007 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.90526848 |
| 131 | MP0002269_muscular_atrophy | 0.90049665 |
| 132 | MP0001919_abnormal_reproductive_system | 0.89943599 |
| 133 | MP0005389_reproductive_system_phenotype | 0.88773194 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.87037697 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.86379333 |
| 136 | MP0003303_peritoneal_inflammation | 0.85629536 |
| 137 | MP0005645_abnormal_hypothalamus_physiol | 0.85340148 |
| 138 | MP0003252_abnormal_bile_duct | 0.85286464 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.85119793 |
| 140 | MP0001544_abnormal_cardiovascular_syste | 0.83961514 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.83961514 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.83774283 |
| 143 | MP0002277_abnormal_respiratory_mucosa | 0.83233591 |
| 144 | MP0004811_abnormal_neuron_physiology | 0.83033620 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.81748472 |
| 146 | MP0002160_abnormal_reproductive_system | 0.81435031 |
| 147 | MP0000716_abnormal_immune_system | 0.80702999 |
| 148 | MP0000569_abnormal_digit_pigmentation | 0.80174847 |
| 149 | MP0008874_decreased_physiological_sensi | 0.79931680 |
| 150 | MP0002163_abnormal_gland_morphology | 0.79196613 |
| 151 | MP0005376_homeostasis/metabolism_phenot | 0.77239242 |
| 152 | MP0005165_increased_susceptibility_to | 0.77146055 |
| 153 | MP0002106_abnormal_muscle_physiology | 0.75942755 |
| 154 | MP0009333_abnormal_splenocyte_physiolog | 0.75276229 |
| 155 | MP0001727_abnormal_embryo_implantation | 0.74986415 |
| 156 | MP0004085_abnormal_heartbeat | 0.74151204 |
| 157 | MP0005535_abnormal_body_temperature | 0.74031690 |
| 158 | MP0003786_premature_aging | 0.73131782 |
| 159 | MP0004133_heterotaxia | 0.72732025 |
| 160 | MP0003718_maternal_effect | 0.70253719 |
| 161 | MP0008775_abnormal_heart_ventricle | 0.67884394 |
| 162 | MP0006138_congestive_heart_failure | 0.67736423 |
| 163 | MP0003123_paternal_imprinting | 0.67500656 |
| 164 | MP0008877_abnormal_DNA_methylation | 0.66774560 |
| 165 | MP0003656_abnormal_erythrocyte_physiolo | 0.66729261 |
| 166 | MP0003879_abnormal_hair_cell | 0.66496763 |
| 167 | MP0008569_lethality_at_weaning | 0.64725100 |
| 168 | MP0003329_amyloid_beta_deposits | 0.64206280 |
| 169 | MP0002229_neurodegeneration | 0.62874802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.19547765 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.72440694 |
| 3 | Mitochondrial inheritance (HP:0001427) | 6.31091954 |
| 4 | Acute encephalopathy (HP:0006846) | 6.00866213 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.93009523 |
| 6 | Hepatocellular necrosis (HP:0001404) | 5.88057097 |
| 7 | Increased CSF lactate (HP:0002490) | 5.57899211 |
| 8 | Hepatic necrosis (HP:0002605) | 5.17256681 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.46086120 |
| 10 | Increased serum pyruvate (HP:0003542) | 4.44236186 |
| 11 | Abnormality of glycolysis (HP:0004366) | 4.44236186 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.38135866 |
| 13 | Cerebral edema (HP:0002181) | 4.25566386 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 4.21854283 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 4.09481853 |
| 16 | Exercise intolerance (HP:0003546) | 4.03901421 |
| 17 | Respiratory failure (HP:0002878) | 4.01162459 |
| 18 | Lactic acidosis (HP:0003128) | 3.97830186 |
| 19 | Renal Fanconi syndrome (HP:0001994) | 3.90656725 |
| 20 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.86057329 |
| 21 | Increased serum lactate (HP:0002151) | 3.81083567 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.77915899 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.77915899 |
| 24 | Pheochromocytoma (HP:0002666) | 3.77750277 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.74137618 |
| 26 | Optic disc pallor (HP:0000543) | 3.56157115 |
| 27 | Leukodystrophy (HP:0002415) | 3.55064977 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 3.51906682 |
| 29 | Myokymia (HP:0002411) | 3.43099029 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.27865177 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 3.27401595 |
| 32 | Abnormal glycosylation (HP:0012345) | 3.27401595 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.27401595 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.27401595 |
| 35 | Exertional dyspnea (HP:0002875) | 3.19222047 |
| 36 | Albinism (HP:0001022) | 3.12185604 |
| 37 | Emotional lability (HP:0000712) | 3.09713876 |
| 38 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.96564824 |
| 39 | Respiratory difficulties (HP:0002880) | 2.90360648 |
| 40 | CNS demyelination (HP:0007305) | 2.86184388 |
| 41 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.81944825 |
| 42 | Abnormality of alanine metabolism (HP:0010916) | 2.81944825 |
| 43 | Hyperalaninemia (HP:0003348) | 2.81944825 |
| 44 | Focal motor seizures (HP:0011153) | 2.79708819 |
| 45 | Stomatitis (HP:0010280) | 2.76445158 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69871690 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69871690 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69871690 |
| 49 | Abnormal number of erythroid precursors (HP:0012131) | 2.68105536 |
| 50 | Microvesicular hepatic steatosis (HP:0001414) | 2.63678595 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.61581629 |
| 52 | Severe visual impairment (HP:0001141) | 2.55407675 |
| 53 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.51236575 |
| 54 | Hypothermia (HP:0002045) | 2.50960897 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.50830247 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.49585194 |
| 57 | Palpitations (HP:0001962) | 2.46721157 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.46050667 |
| 59 | Lethargy (HP:0001254) | 2.45802131 |
| 60 | Atonic seizures (HP:0010819) | 2.41823962 |
| 61 | Poor suck (HP:0002033) | 2.41347029 |
| 62 | Ragged-red muscle fibers (HP:0003200) | 2.37475123 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.35919479 |
| 64 | Abnormality of renal resorption (HP:0011038) | 2.27377070 |
| 65 | X-linked dominant inheritance (HP:0001423) | 2.26506529 |
| 66 | Delusions (HP:0000746) | 2.21647279 |
| 67 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21159508 |
| 68 | Molar tooth sign on MRI (HP:0002419) | 2.17771150 |
| 69 | Abnormality of midbrain morphology (HP:0002418) | 2.17771150 |
| 70 | Poor head control (HP:0002421) | 2.17602240 |
| 71 | Ketoacidosis (HP:0001993) | 2.17542638 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.16284684 |
| 73 | Pancreatic cysts (HP:0001737) | 2.14488630 |
| 74 | Limb dystonia (HP:0002451) | 2.14399585 |
| 75 | Myotonia (HP:0002486) | 2.13523737 |
| 76 | Pancytopenia (HP:0001876) | 2.12668031 |
| 77 | Gliosis (HP:0002171) | 2.12608243 |
| 78 | Opisthotonus (HP:0002179) | 2.12361124 |
| 79 | Abnormality of the vocal cords (HP:0008777) | 2.12154774 |
| 80 | Attenuation of retinal blood vessels (HP:0007843) | 2.11400554 |
| 81 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.08883262 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.05498508 |
| 83 | Polydipsia (HP:0001959) | 2.05498508 |
| 84 | Ketosis (HP:0001946) | 2.04135465 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.02125640 |
| 86 | Cholecystitis (HP:0001082) | 2.02125640 |
| 87 | Progressive microcephaly (HP:0000253) | 2.00236277 |
| 88 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98008427 |
| 89 | Hypoplasia of the fovea (HP:0007750) | 1.98008427 |
| 90 | Methylmalonic aciduria (HP:0012120) | 1.96224543 |
| 91 | Abnormal hair whorl (HP:0010721) | 1.93094806 |
| 92 | Macrocytic anemia (HP:0001972) | 1.91566895 |
| 93 | Glycosuria (HP:0003076) | 1.90674934 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 1.90674934 |
| 95 | Progressive external ophthalmoplegia (HP:0000590) | 1.90651221 |
| 96 | Hyperphosphaturia (HP:0003109) | 1.90292977 |
| 97 | Unsteady gait (HP:0002317) | 1.90158782 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90059313 |
| 99 | IgG deficiency (HP:0004315) | 1.87458591 |
| 100 | Abnormality of serum amino acid levels (HP:0003112) | 1.87120538 |
| 101 | Hyperventilation (HP:0002883) | 1.83977143 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83321427 |
| 103 | Aplastic anemia (HP:0001915) | 1.82447802 |
| 104 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81789630 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79496932 |
| 106 | Vomiting (HP:0002013) | 1.79171305 |
| 107 | Conjunctival hamartoma (HP:0100780) | 1.78479521 |
| 108 | Pancreatic fibrosis (HP:0100732) | 1.78412858 |
| 109 | Nausea (HP:0002018) | 1.78311837 |
| 110 | Petechiae (HP:0000967) | 1.78194128 |
| 111 | Pendular nystagmus (HP:0012043) | 1.77286869 |
| 112 | Large for gestational age (HP:0001520) | 1.76633149 |
| 113 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75868472 |
| 114 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75758445 |
| 115 | Hypokinesia (HP:0002375) | 1.75173579 |
| 116 | Sensory axonal neuropathy (HP:0003390) | 1.75130507 |
| 117 | Postnatal microcephaly (HP:0005484) | 1.75035975 |
| 118 | Hypomagnesemia (HP:0002917) | 1.74976329 |
| 119 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74565382 |
| 120 | Abnormality of the anterior horn cell (HP:0006802) | 1.72335467 |
| 121 | Degeneration of anterior horn cells (HP:0002398) | 1.72335467 |
| 122 | CNS hypomyelination (HP:0003429) | 1.71078931 |
| 123 | Blindness (HP:0000618) | 1.70996404 |
| 124 | Calf muscle hypertrophy (HP:0008981) | 1.70592784 |
| 125 | Neoplasm of head and neck (HP:0012288) | 1.70537090 |
| 126 | Esophageal neoplasm (HP:0100751) | 1.70537090 |
| 127 | Microretrognathia (HP:0000308) | 1.70361674 |
| 128 | Rhabdomyolysis (HP:0003201) | 1.69891085 |
| 129 | Abnormality of the pons (HP:0007361) | 1.69507742 |
| 130 | Hypoplasia of the pons (HP:0012110) | 1.68924332 |
| 131 | Type I transferrin isoform profile (HP:0003642) | 1.68826291 |
| 132 | Tongue fasciculations (HP:0001308) | 1.68757592 |
| 133 | Cutaneous melanoma (HP:0012056) | 1.68453147 |
| 134 | Retinal dysplasia (HP:0007973) | 1.67234804 |
| 135 | Exercise-induced muscle cramps (HP:0003710) | 1.67141464 |
| 136 | Hyperglycinemia (HP:0002154) | 1.66870548 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.66341688 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.65223122 |
| 139 | Oral leukoplakia (HP:0002745) | 1.64864698 |
| 140 | Dicarboxylic aciduria (HP:0003215) | 1.64750173 |
| 141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.64750173 |
| 142 | Metabolic acidosis (HP:0001942) | 1.64435177 |
| 143 | Tinnitus (HP:0000360) | 1.64434482 |
| 144 | Abnormality of the fovea (HP:0000493) | 1.64141434 |
| 145 | Abnormal pupillary function (HP:0007686) | 1.63312223 |
| 146 | Sudden death (HP:0001699) | 1.62097875 |
| 147 | Absence seizures (HP:0002121) | 1.61688303 |
| 148 | Renal tubular dysfunction (HP:0000124) | 1.59941115 |
| 149 | Anxiety (HP:0000739) | 1.59195755 |
| 150 | Muscle stiffness (HP:0003552) | 1.56409251 |
| 151 | Dialeptic seizures (HP:0011146) | 1.56384185 |
| 152 | Reticulocytopenia (HP:0001896) | 1.55869947 |
| 153 | Methylmalonic acidemia (HP:0002912) | 1.51556445 |
| 154 | Neoplasm of the adrenal gland (HP:0100631) | 1.50707275 |
| 155 | Type 2 muscle fiber atrophy (HP:0003554) | 1.50434098 |
| 156 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.49714193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.22239339 |
| 2 | MAP3K12 | 3.80825741 |
| 3 | STK16 | 3.45951437 |
| 4 | ARAF | 3.29961598 |
| 5 | NME2 | 2.74600874 |
| 6 | MYLK | 2.73971520 |
| 7 | BUB1 | 2.67252397 |
| 8 | VRK2 | 2.49362643 |
| 9 | PDK2 | 2.47251266 |
| 10 | NME1 | 2.35437177 |
| 11 | TRIM28 | 2.33000423 |
| 12 | CDK19 | 2.21137310 |
| 13 | GRK5 | 2.18268733 |
| 14 | CASK | 2.10688805 |
| 15 | TXK | 2.08321149 |
| 16 | LIMK1 | 2.03707289 |
| 17 | NUAK1 | 1.94003510 |
| 18 | BRAF | 1.83294883 |
| 19 | MAP2K7 | 1.79949869 |
| 20 | EIF2AK1 | 1.79607079 |
| 21 | PIM2 | 1.77219021 |
| 22 | BCKDK | 1.71625897 |
| 23 | TESK1 | 1.70973750 |
| 24 | TSSK6 | 1.69949942 |
| 25 | GRK7 | 1.65179598 |
| 26 | MAP4K2 | 1.64826618 |
| 27 | TESK2 | 1.61375528 |
| 28 | GRK1 | 1.57243438 |
| 29 | DAPK1 | 1.55292386 |
| 30 | CCNB1 | 1.47518968 |
| 31 | WNK3 | 1.45677478 |
| 32 | IKBKB | 1.45563768 |
| 33 | WEE1 | 1.43119338 |
| 34 | OBSCN | 1.42610193 |
| 35 | BMPR1B | 1.41653807 |
| 36 | VRK1 | 1.38541961 |
| 37 | MINK1 | 1.36178720 |
| 38 | PLK2 | 1.31904696 |
| 39 | EIF2AK3 | 1.31822418 |
| 40 | MUSK | 1.25270556 |
| 41 | MARK3 | 1.24940212 |
| 42 | TIE1 | 1.22413864 |
| 43 | IRAK3 | 1.21572635 |
| 44 | DAPK3 | 1.21115652 |
| 45 | MAP3K11 | 1.21038541 |
| 46 | KDR | 1.18263636 |
| 47 | OXSR1 | 1.17334980 |
| 48 | RIPK4 | 1.15532232 |
| 49 | NEK1 | 1.09930718 |
| 50 | DAPK2 | 1.02712030 |
| 51 | PRPF4B | 0.98757151 |
| 52 | ILK | 0.98519798 |
| 53 | PDK4 | 0.98290859 |
| 54 | PDK3 | 0.98290859 |
| 55 | TAOK3 | 0.98097387 |
| 56 | ABL2 | 0.94362725 |
| 57 | CDK8 | 0.93782399 |
| 58 | CSNK1G1 | 0.93135923 |
| 59 | CAMKK2 | 0.92824688 |
| 60 | TNIK | 0.92499725 |
| 61 | TAOK2 | 0.92475546 |
| 62 | MAP2K4 | 0.90739980 |
| 63 | AURKA | 0.89549575 |
| 64 | TLK1 | 0.86040825 |
| 65 | NTRK3 | 0.85680331 |
| 66 | MAP3K9 | 0.84657089 |
| 67 | BMPR2 | 0.84150057 |
| 68 | PLK1 | 0.83865212 |
| 69 | RAF1 | 0.82629360 |
| 70 | PBK | 0.82275693 |
| 71 | MAP4K1 | 0.81963021 |
| 72 | MAPKAPK5 | 0.81862744 |
| 73 | MAP2K6 | 0.81489547 |
| 74 | CDC7 | 0.80804533 |
| 75 | ADRBK2 | 0.80302288 |
| 76 | TEC | 0.80068740 |
| 77 | MST4 | 0.80031905 |
| 78 | PTK2B | 0.78176137 |
| 79 | BRSK1 | 0.78116021 |
| 80 | SIK3 | 0.77866422 |
| 81 | PRKCI | 0.77026255 |
| 82 | CDK14 | 0.76491011 |
| 83 | CAMK2G | 0.76426162 |
| 84 | SRPK1 | 0.76134614 |
| 85 | GRK6 | 0.76083532 |
| 86 | MAPKAPK3 | 0.72707573 |
| 87 | PLK4 | 0.71486361 |
| 88 | CSNK1A1L | 0.70453641 |
| 89 | MAP3K4 | 0.69162918 |
| 90 | PINK1 | 0.69052863 |
| 91 | CSNK1G3 | 0.69030049 |
| 92 | MOS | 0.68717458 |
| 93 | CSNK1G2 | 0.68650635 |
| 94 | CAMK2B | 0.67975621 |
| 95 | KSR2 | 0.67506204 |
| 96 | RPS6KA5 | 0.67072837 |
| 97 | MAP3K13 | 0.66501854 |
| 98 | BCR | 0.66198870 |
| 99 | CDK18 | 0.65706093 |
| 100 | MAP3K5 | 0.65634684 |
| 101 | PIM1 | 0.64933153 |
| 102 | CAMK2A | 0.64082340 |
| 103 | STK10 | 0.63484723 |
| 104 | STK39 | 0.62428204 |
| 105 | PAK1 | 0.60683027 |
| 106 | MATK | 0.60157802 |
| 107 | CDK15 | 0.59824686 |
| 108 | CAMK2D | 0.58923530 |
| 109 | BLK | 0.58646551 |
| 110 | CDK11A | 0.58190347 |
| 111 | TBK1 | 0.57835031 |
| 112 | PAK3 | 0.57801826 |
| 113 | PIK3CG | 0.56769629 |
| 114 | FES | 0.55926083 |
| 115 | ROCK2 | 0.55844531 |
| 116 | ZAK | 0.55626572 |
| 117 | MAP3K3 | 0.55554499 |
| 118 | MAPK13 | 0.55351776 |
| 119 | IKBKE | 0.55009756 |
| 120 | PRKCG | 0.54452861 |
| 121 | WNK4 | 0.52551443 |
| 122 | BRSK2 | 0.52027840 |
| 123 | INSRR | 0.50848021 |
| 124 | SCYL2 | 0.50149128 |
| 125 | DYRK2 | 0.48645671 |
| 126 | PLK3 | 0.48507146 |
| 127 | LYN | 0.48389137 |
| 128 | ADRBK1 | 0.47811426 |
| 129 | EPHA4 | 0.47121813 |
| 130 | MKNK2 | 0.46423540 |
| 131 | ATR | 0.44738955 |
| 132 | CSNK2A1 | 0.44468814 |
| 133 | PNCK | 0.43123185 |
| 134 | KIT | 0.42950588 |
| 135 | MAP2K3 | 0.42645566 |
| 136 | TGFBR2 | 0.42507190 |
| 137 | IRAK1 | 0.42443293 |
| 138 | SYK | 0.42308773 |
| 139 | IRAK4 | 0.41610728 |
| 140 | NTRK1 | 0.41138825 |
| 141 | PRKCD | 0.40948947 |
| 142 | CSNK2A2 | 0.40433522 |
| 143 | STK4 | 0.39975857 |
| 144 | STK24 | 0.39767267 |
| 145 | CSNK1A1 | 0.39590953 |
| 146 | FLT3 | 0.39387998 |
| 147 | UHMK1 | 0.38705922 |
| 148 | PRKCQ | 0.38646034 |
| 149 | ACVR1B | 0.38124850 |
| 150 | PRKCE | 0.35390922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.91791121 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.28918337 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.42304716 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.75066508 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.67170280 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 3.63070275 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.92941023 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.78186124 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74354246 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.70926178 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38922228 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.97560473 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93433843 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.76486357 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74473335 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59335737 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.56183829 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55476975 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.50804550 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40481879 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32108967 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27627518 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25325284 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22661579 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21777751 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20726650 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19020834 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16933911 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16367974 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12087717 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11575603 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11295828 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.10724691 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.09030916 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.07928350 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06969388 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06623807 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04863278 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02667349 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01730830 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.01697927 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.98756594 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 0.97028687 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96878626 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95486997 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 0.93487882 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91743780 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.90606250 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.90120545 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88641998 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.88382079 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87271135 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86804191 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85055362 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84945622 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83492712 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83035195 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82303140 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81619139 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81456149 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80760314 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77883277 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74433959 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73948404 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.73905612 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.73241376 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70548441 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69509515 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68437442 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68306803 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66899105 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.66804124 |
| 73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65543271 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65374851 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.63603370 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63305746 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61718020 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60396006 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60001001 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59890500 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58820279 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58661296 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58624803 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57258306 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55193946 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54440026 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54248890 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53734873 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53226700 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52143004 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51382898 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50711229 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49887723 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.49682535 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49076983 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47688145 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46854424 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46137004 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45927869 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45018413 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.44224118 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43333068 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42793614 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.42193008 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40299115 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38722575 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.37800193 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35400792 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35303541 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34884921 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34455929 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33419834 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33035147 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32919408 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30551041 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29326683 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28520003 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28024980 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27741035 |
| 120 | Taste transduction_Homo sapiens_hsa04742 | 0.27091078 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25047547 |
| 122 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23239032 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20510734 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.19481206 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.19362354 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18702478 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18065996 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15081225 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.13889078 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.11571733 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.10503181 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.10394245 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10291700 |
| 134 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.09277732 |
| 135 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.09186236 |
| 136 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09037188 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.08583881 |
| 138 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.08368280 |

